Minoxidil in severe hypertension with renal failure. Effect of its addition to conventional antihypertensive drugs.
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D005665:Furosemide / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D006983:Hypertrichosis / Q000139:chemically induced; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D008914:Minoxidil / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced; D010880:Piperidines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D010880:Piperidines; D011743:Pyrimidines; D006852:Hydrochlorothiazide; D006830:Hydralazine; D008750:Methyldopa; D008914:Minoxidil; D005665:Furosemide; D006145:Guanethidine